HOME >> BIOLOGY >> NEWS
Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture

Biomaterials and how they will change our lives

Philadelphia--Robert S. Langer, Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology, has been chosen to deliver the 2001 Ullyot Public Affairs Lecture with a presentation titled "Biomaterials and How They Will Change Our Lives." The lecture, scheduled to take place at the Chemical Heritage Foundation on Thursday, 20 September 2001, will discuss advances in drug delivery that have revolutionized the medical industry. Since joining the MIT faculty in 1977, Langer has specialized in controlled drug delivery and tissue engineering. His discoveries are at the heart of today's multi-billion dollar controlled drug delivery industry and have provided a framework for the emerging technology of tissue engineering. Much of Langer's research has been in biomedical applications of polymers, and his groundbreaking research dispelled the belief that only some sizes of molecules could be delivered slowly.

Langer's later research has led to the development of a number of novel biodegradable polymers with medical applications. One of these resulted in a drug delivery system for the treatment of brain cancer (developed with Dr. Henry Brem of Johns Hopkins University Medical School)-the first FDA-approved treatment for brain cancer in 20 years and the first polymer-based treatment to deliver chemotherapy directly to a tumor site. This treatment has extended the lives of numerous patients and has far fewer side effects than conventional chemotherapy.

Langer has received over eighty major awards. In 1996, he became the only engineer to receive the Gairdner Foundation International Award; fifty-four recipients of this award have subsequently received a Nobel Prize. He received the $500,000 Lemelson-MIT prize, the world's largest prize for invention, in 1998 for being, "one of history's most prolific inventors in medicine," and
'"/>

Contact: Scott P. Lockledge
scottl@chemheritage.org
215-925-2222
Chemical Heritage Foundation
21-Aug-2001


Page: 1 2

Related biology news :

1. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
2. UC Riversides professor Robert Graham elected Fellow of the Soil Science Society of America
3. Robert Horvitz, pioneer in cell death, to be awarded international genetics prize
4. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
5. DFG presents the 2004 MAK and BAT value lists
6. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
7. National study shows dog and cat allergens are universally present in U.S. homes
8. VIB presents its annual results at BIO2004 in San Francisco
9. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
10. AACR awards scholarships to minority and underrepresented scientists
11. Steroid-coated DNA represents new approach to gene delivery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Robert Langer present the Ullyot Public Affairs Lecture

(Date:6/24/2015)... June 24, 2015 Biometry authentication provider ... biometric password solution one face in. ... one face in, entering the expanding biometric ... affordable multifactor-authentication biometric answer to the password problem. ... in partnership with KeyLemon, one face in allows ...
(Date:6/23/2015)... 22, 2015 Research ... of the "Body-Worn Temperature Sensors Market - ... Forecast 2014 - 2020" report to their ... of the global body-worn temperature sensors market. The ... on the basis of types, care setting, patient ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
(Date:6/30/2015)... Americord Registry, one of the fastest growing cord blood banks ... at Kirkland & Ellis LLP, as the newest member of ...   "We are thrilled about Andrew Horne,s ... , CEO of Americord. "He brings a wealth of knowledge ... growth and vision." Andrew Horne is ...
(Date:6/30/2015)... ... ... The maximum number of shares proposed to be purchased in the tender ... restricted stock). On June 29, 2015, the last trading day prior to the commencement ... OTCBB was $2.29 per share. , The tender offer will expire on July 28, ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel ... clinical stage regenerative medicine company focused on the ... first participant in its Phase 1/2 clinical trial ... chronic unilateral Achilles tendinosis, has been enrolled and ... intra-tendon ultrasound-guided injections. RCT-01 is comprised of non-bulbar ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... digital media company, launched “Cannavoices,” an unprecedented digital video and broadcast initiative. Produced ... also the most dynamic collection of legal medical cannabis stories ever assembled. ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
Cached News: